Mera Pharmaceuticals, Inc.
MRPI
$0.00
$0.000.00%
10/31/2011 | 07/31/2011 | 04/30/2011 | 01/31/2011 | 10/31/2010 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 4.30K | 4.00K | 1.30K | 7.00K | 5.90K |
Total Receivables | 7.80K | 14.20K | 12.40K | 9.60K | 8.90K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 42.30K | 32.40K | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 54.50K | 50.60K | 13.70K | 16.50K | 14.80K |
|
|||||
Total Current Assets | 54.50K | 50.60K | 13.70K | 16.50K | 14.80K |
Net Property, Plant & Equipment | 2.00K | 4.10K | 6.30K | 5.20K | 8.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 14.20K | 30.00K | 26.50K | 22.70K | 50.50K |
Total Assets | 70.70K | 84.80K | 46.40K | 44.40K | 73.40K |
|
|||||
Total Accounts Payable | 486.20K | 427.10K | 380.20K | 364.90K | 373.70K |
Total Accrued Expenses | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K |
Short-term Debt | 299.10K | 51.90K | 51.90K | 51.90K | 226.60K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | 218.20K | 211.00K | 189.20K | -- |
Total Other Current Liabilities | -- | 218.20K | 211.00K | 189.20K | -- |
Total Current Liabilities | 935.30K | 847.20K | 793.10K | 756.10K | 750.30K |
|
|||||
Total Current Liabilities | 935.30K | 847.20K | 793.10K | 756.10K | 750.30K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 299.10K | 51.90K | 51.90K | 51.90K | 226.60K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 935.30K | 847.20K | 793.10K | 756.10K | 750.30K |
|
|||||
Common Stock & APIC | 8.02M | 8.02M | 8.02M | 8.02M | 8.02M |
Retained Earnings | -8.89M | -8.78M | -8.77M | -8.73M | -8.70M |
Treasury Stock & Other | -2.00K | -2.00K | -2.00K | -2.00K | -2.00K |
Total Common Equity | -864.60K | -762.40K | -746.70K | -711.60K | -676.90K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|||||
Total Common Equity | -864.60K | -762.40K | -746.70K | -711.60K | -676.90K |
Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -864.60K | -762.40K | -746.70K | -711.60K | -676.90K |
|